tradingkey.logo
搜尋

Boston Scientific Corp

BSX
添加自選
44.205USD
-0.255-0.57%
收盤 06/25, 16:00美東報價延遲15分鐘
65.70B總市值
18.39本益比TTM

關於 Boston Scientific Corp 公司

Boston Scientific Corporation is a global developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. The Company's MedSurg segment includes Endoscopy, Urology, and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a range of gastrointestinal conditions with less-invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies, including kidney stones, benign prostatic hyperplasia, prostate cancer, erectile dysfunction, and incontinence. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. The Cardiology includes interventional cardiology therapies, watchman, cardiac rhythm management, and electrophysiology.

Boston Scientific Corp簡介

公司代碼BSX
公司名稱Boston Scientific Corp
上市日期May 19, 1992
CEOMahoney (Michael F)
員工數量53000
證券類型Ordinary Share
年結日May 19
公司地址300 Boston Scientific Way
城市MARLBOROUGH
上市交易所NASDAQ OMX NASDAQ Basic NYSE
國家United States of America
郵編01752-1234
電話15086834000
網址https://www.bostonscientific.com/en-US/Home.html
公司代碼BSX
上市日期May 19, 1992
CEOMahoney (Michael F)

Boston Scientific Corp公司高管

名稱
名稱/職務
職務
持股
持股變動
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%
Mr. David C. Habiger
Mr. David C. Habiger
Independent Director
Independent Director
13.88K
+59.45%
Mr. Yoshiaki Fujimori
Mr. Yoshiaki Fujimori
Independent Director
Independent Director
2.08K
--
Mr. Joseph M. Fitzgerald
Mr. Joseph M. Fitzgerald
Executive Vice President, Group President - Cardiology
Executive Vice President, Group President - Cardiology
--
--
Mr. Edward J. Ludwig
Mr. Edward J. Ludwig
Lead Independent Director
Lead Independent Director
--
--
查看更多
名稱
名稱/職務
職務
持股
持股變動
Mr. Michael F. (Mike) Mahoney
Mr. Michael F. (Mike) Mahoney
Chairman of the Board, President, Chief Executive Officer
Chairman of the Board, President, Chief Executive Officer
1.86M
+0.66%
Mr. John E. Sununu
Mr. John E. Sununu
Independent Director
Independent Director
54.72K
--
Mr. Vance R. Brown
Mr. Vance R. Brown
Senior Vice President, General Counsel, Corporate Secretary
Senior Vice President, General Counsel, Corporate Secretary
54.24K
--
Mr. David S. (Dave) Wichmann
Mr. David S. (Dave) Wichmann
Independent Director
Independent Director
45.38K
+8.37%
Mr. Jonathan R. Monson
Mr. Jonathan R. Monson
Chief Financial Officer, Executive Vice President
Chief Financial Officer, Executive Vice President
37.99K
--
Ms. Ellen M. Zane
Ms. Ellen M. Zane
Independent Director
Independent Director
27.93K
+13.60%

常見問題

Boston Scientific Corp的前五大股東是誰?

Boston Scientific Corp的前五大股東如下:Mr. Michael F. (Mike) Mahoney

有多少機構持有Boston Scientific Corp(BSX)的股份?

截至2026Q1,共有3113家機構持有Boston Scientific Corp的股份,合計持有的股份價值約為1.40B,占公司總股份的94.35% 。與2025Q4相比,機構持股有所增加,增幅為-15512534.00。

哪個業務部門對Boston Scientific Corp的收入貢獻最大?

在2026Q1,Interventional Cardiology Therapies業務部門對Boston Scientific Corp的收入貢獻最大,創收4.64B,占總收入的23.11% 。
KeyAI